Introduction {#Sec1}
============

Peptides or proteins are one of the primary "natural antibiotics" which exert considerable antimicrobial effects against a wide range of microorganisms, including Gram-positive and Gram-negative bacteria, yeast, filamentous fungi and to a lesser extent, protozoans and enveloped viruses. Some of these natural antibiotics may be hemolytic and cytotoxic to cancer cells \[[@CR2]\]. Plants are valuable sources of compounds that can effectively combat bacterial diseases and tumors. Their role in case of viral disease is contained *Corona* virus, *Coxsackie* virus, Dengue virus, *Enterovirus*, herpes simplex, measles virus respiratory syncytial virus, influenza, human immunodeficiency, hepatitis B and C \[[@CR36]\].

Considering chemotherapeutics failure and increasing trend of antibiotic and antiviral resistance, it is essential to search for novel/more efficient antibiotics. Extensive research has been done to discover new alternative antimicrobial and antiviral agents from natural sources \[[@CR3], [@CR34]\]. One of the phytochemicals possessing such activities, is proteins \[[@CR6]\].

Genus *Pistacia* with approximately ten members, belongs to the family Anacardiaceae \[[@CR32]\]. *Pistacia vera* L. is recognized as a delicious nut with several nutritional benefits \[[@CR30]\]. Due to its highly favorable taste, nutritional value, and health promoting composition, it is consumed worldwide as a snack (fresh or roasted and salted), pistachio halva, pistachio milk, pistachio butter, etc. Furthermore, pistachio is normally used as an ingredient in cakes, confectionery products, biscuits, candies, ice creams and chocolates \[[@CR28], [@CR31]\]. Pistachio contains various essential nutrients that can contribute to a healthy diet \[[@CR10]\]. It means that pistachio allergens are from protein families of 2S albumins (Pis v 1), legumins (Pis v 2 and Pis v 5), vicilins (Pis v3), and iron/ manganese superoxide dismutase (Pis v 4) \[[@CR11]\]. It is obvious that certain allergenic proteins, typically those which are stable towards heat and digestion, are the primary cause of an immune response \[[@CR18]\]. Characterization of pistachio allergens helps to explain the possible cross-reactivity among tree nut allergens and is the first step towards development of better diagnostic and therapeutic approaches \[[@CR1]\].

The *Coxsackie* viruses of group B (*C*V*-B1-6*) is a positive-sense single-stranded RNA virus belonging to *Entero*virus genus, and Picornaviridae family. *C*V*-B1-6* is known as the most common viral cause of acute and chronic diseases such as human heart infections, and is involved in the development of type I diabetes, myocarditis and central nervous system pathologies, especially among new-born and infants \[[@CR5], [@CR26]\]. From another medicinal point of view, natural compounds have good cytotoxicity profile and their highly selective toxicity makes them promising candidates to be used as adjuvants to anticancer therapeutics to overcome multidrug resistance phenomenon \[[@CR16]\].

Various methods have been used for detection of food allergens. The most common quantitative methods used for allergen detection in food, are enzyme-linked immunosorbent assay (ELISA) and real-time PCR. But, it is difficult to detect multiple allergens using an ELISA assay. By using more specific, more quantitative and more sensitive methodologies, trace levels of allergens were also detected in food. As a highly sensitive apparatus, Liquid chromatography- mass spectrometry (LC--MS) has been employed to detect multiple allergens in nuts \[[@CR18], [@CR19]\]. To identify peptides, we used a quadrupole time-of-flight (q-TOF) mass spectrometer which enabled us to purify multiple allergens in a short time.

As there are few reports on biological properties of allergenic proteins, we were motivated us to evaluate the (1) antimicrobial, (2) antiviral (against *Coxsackie* viruses) and (3) cytotoxic effects of allergenic proteins isolated from pistachio.

Materials and methods {#Sec2}
=====================

Chemicals and plant material {#Sec3}
----------------------------

The ripe fruits of pistachio (*P. vera*) ("Kalehghoochi" cultivar) were collected from a commercial orchard of Rafsanjan (at 30° 41ʹ N and 55° 09 ʹ E; 1580.9 m above sea level), Kerman province, Iran. Kernels, hull and hard shells of fruits were separated and the kernels were air-dried at room temperature, ground and then stored at 4 °C until analysis. [l]{.smallcaps}-Glutamine, penicillin, streptomycin, nystatin, amphotericin B, fetal bovine serum (FBS), Eagle's Minimal Essential Medium (MEM), fetal calf serum (FCS), non-essential amino acids and trypsin were obtained from GIBCO. Hexane, TRIS/HCl, dibasic sodium phosphate, acetonitrile, trifluoroacetic acid (TFA), 3-(4,5-dimethylthiazole-2-yl)-2,5-biphenyl tetrazolium bromide (MTT), soybean casein digest agar (SCDA), normal saline (NS), Mueller--Hinton broth (MHB), 2,3,5-triphenyltetrazolium chloride (TTC), Sabouraud\'s dextrose broth (SDB), phosphate-buffered saline (PBS), dimethyl sulfoxide (DMSO) and RPMI 1640 medium were procured from Sigma Aldrich (Europe).

Protein isolation {#Sec4}
-----------------

### Defatting pistachio powder {#Sec5}

Pistachio kernel powder was extracted using hexane at 1:5 (v:v) ratio and stirred thoroughly for 1 h at room temperature. The lipid fraction was removed and the precipitate was air-dried in a draft chamber, overnight. The defatting process was repeated in order to produce a completely dried powder. The defatted pistachio kernel powder (DPKP) was stored at − 80 °C \[[@CR9]\].

Protein isolation {#Sec6}
-----------------

Protein extraction was performed using a slightly modified method that was previously described by Sealey-Voyksner et al. \[[@CR18]\]. For this purpose, 30 mg of DPKP was extracted for 2 h at 50 °C using 1 mL of TRIS/HCl (50 mM, pH 7.5); other solvent used for this purpose were HCl (0.01 M, pH 2.5) and dibasic sodium phosphate (50 mM, pH 8). The DPKP extracts (with the exception of those subjected to enzymatic digestion) were centrifuged at 8000×*g* for 10 min and the supernatant was collected for analysis by LC--MS for the presence of proteins. For enzymatic digestion, we added trypsin to samples extracted with 50 mM TRIS/HCl (pH 7.5). Also, 25 µL of 12 mg/mL trypsin solution was dissolved in 50 mM sodium phosphate and the mixture was added to the samples and incubated at 38 °C for 2 h while vortexed every 15 min; after this time, 200 µL of acetonitrile with 0.2% TFA was added to the sample. The digested sample was centrifuged at 8000×*g* for 10 min and the upper 200 µL was fractionated into a 96-well plate for LC--MS/MS analysis \[[@CR18]\].

Liquid chromatography--mass spectrometry (LC--MS) {#Sec7}
-------------------------------------------------

Liquid chromatography-mass spectrometry (LC--MS) for pistachio proteins and trypsin digest analysis, was carried out by an Agilent 1290 LC system (Agilent Santa Clara, CA, USA) coupled with an Agilent 6530 quadrupole time-of-flight (q-TOF) mass spectrometer to identify peptides that represent known pistachio proteins.

Protein analysis {#Sec8}
----------------

The DPKP proteins were separated on an Agilent Poroshell 300 column (2.1 × 75 mm, 2.7 µm, 300 A°; Agilent, Santa Clara, CA, USA, using a gradient of 0 to 40% of solution I for 70 min (solution I comprised of 95% water + 5% acetonitrile + 0.025% TFA) and solution II (solution II comprised of 5% water + 95% acetonitrile + 0.025% TFA), then from 40% solution II to 60% solution II at 80 min at a flow rate of 0.3 mL/min. The temperature of column was held at 30 °C for the analysis. The injection volume was 20.0 µL.

For q-TOF--MS operation, the electrospray positive ion detection mode was set up in 2 GHz extended dynamic range mode. The duration of scanning was 0.5 s from *m/z* 300 to 2800. The electrospray characteristics were: drying gas 350 °C at 9 L/min, nebulizer gas (nitrogen; flow 10 L/min) and sheath gas 350 °C at 11 L/min, capillary voltage 4000 V, nozzle voltage 1000 V, and fragmentor voltage 160 V.

Peptide analysis {#Sec9}
----------------

The digested sample was analyzed by an Agilent Poroshell 120 column (2.1 × 50 mm, 2.7 µm) using a gradient of 0--40% solution II for 70 min then 40--60% solution II for 80 min with a flow rate of 0.25 mL/min. The column temperature for the analysis was 30 °C and the injection volume was 20 µL. The q-TOF--MS operation was conducted as in a same way as that done for protein analysis. The auto MS/MS was also operated for the most intense precursor ions that were selected via single MS before, by considering \> 15,000 counts from 600 to 2100 m*/z*. For MS/MS, nitrogen was used as collision gas and the collision energy was 10 eV. The MS/MS spectrum was operated in the positive ion as follows: Agilent at 3 spectra/sec over 60--2100 m*/z* with capillary voltage 4000 V, nozzle voltage 1000 V, fragmentor voltage 160 V, and collision energy of 10 eV.

Detection in database {#Sec10}
---------------------

The Agilent technology (The Spectrum Mill MS Proteomics, workbench Rev B.04.00127) was used to search the database. Searches were based on a mass tolerance window of 20 ppm for precursor ion and 50 ppm window for the product ions around the measured m/z. The search used trypsin digestion with up to two missed cleavages with no modifications. The LC--MS data from the tryptic digests of pistachio proteins were searched to identify peptide sequences from the major peaks in the LC--MS run and to match the identified peptide to a specific pistachio protein. A MS scoring algorithm was used to match ions present in the spectrum with the sequence based upon factors described by Kapp et al. \[[@CR13]\]. Scores of 15 and above are well assigned fragmentation and correct interpretation. Scores that were greater than 10 were very good and usually right. Spectrum Mill was used to confirm the amino acid sequences based on the acquired MS spectra as a secondary confirmation of the postulated sequence. Spectrum Mill was also used to verify that these sequences were unique to the pistachio analyzed (based on the search sequence in the green plant NCBInr database using MS Edman program) and would not be found in other nuts or green plants. The sequencing process was done at Department of Molecular Biochemistry, Faculty of Chemistry, University of Gdańsk, Poland \[[@CR18]\].

Peptide standards {#Sec11}
-----------------

High resolution MS/MS was used to confirm the identity of the peptide. All the peptide standards (2S albumin MS Spec standard: CAT No. A8471; and 11S globulin Analytical Standard: CAT No. P8119) were purchased from Sigma Aldrich (Europe).

In order to make 1 mg/mL stock solution, each peptide was dissolved in water: acetonitrile (80:20 ratios) then, diluted to make the threshold standard of 0.1 ppm.

Protein content {#Sec12}
---------------

Protein was quantified by Bradford assay. The assay calibration was set over the range of 25--2000 μg /mL and bovin albumin was used as the standard protein.

Antimicrobial activity {#Sec13}
----------------------

### Strains and growth condition {#Sec14}

DPKP-isolated allergens' antimicrobial properties were examined against 4 Gram-positive \[*Staphylococcus aureus* (PTCC (Persian Type Culture Collection) 1431), *Staphylococcus epidermidis* (PTCC 1435), *Micrococcus luteus* (ATCC (American Type Culture Collection) 9341) and *Bacillus cereus* (PTCC 1247)\], 4 Gram-negative \[(*Pseudomonas aeruginosa* (PTCC 1074), *Salmonella typhi* (PTCC 1609), *Serratia marcescens* (PTCC 1267) and *Escherichia coli* (ATCC 1533)\] bacteria and 2 fungi \[(*Candida albican*s (ATCC 10231) and *Aspergillus niger* (ATCC 16404)\]. A fresh culture media for each microorganism was prepared separately. For bacterial strains, the culture media was prepared through 24 h incubation at 37 °C on SCDA and the bacterial population was adjusted to 10^6^ CFU/mL using normal saline (NS 0.9%). Then, microorganisms were cultured at 25 °C for 48 h on SCDA, and adjusted to 10^6^ CFU/mL by sterile 0.9% NS to be tested against fungal strains \[[@CR33]\].

### Minimum inhibitory concentration and minimum bactericidal and fungicidal concentrations {#Sec15}

Minimum inhibitory concentration (MIC) of DPKP-isolated allergens was determined by the micro-dilution method using 96-microwell culture plates. Accordingly, in order to prepare the first concentration (10% v/v) of each DPKP-isolated allergen, 650 μL of each allergen was added to 325 μL DMSO and the final volume of the mixture was adjusted to 6.5 mL using MHB. The other concentrations of DPKP-isolated allergens were made by using two-fold serial dilution method. A mixture of 200 μL of each concentration of DPKP-isolated allergens and 20 μL of bacterial suspension (10^6^ CFU/mL), was added to each well of a 96-well culture plate. For each bacterium, the experiment was done in duplicate. Also, MHB with DMSO and the microorganisms (with exception DPKP-isolated allergen) served as the negative control. After 24 h incubation at 37 °C, 20 µL of TTC (5 mg/mL) was added to each well for bacterial growth estimation. The lowest concentration of the DPKP-isolated allergens inhibiting the formation of red color in culture media was considered the minimum inhibitory concentration (MIC). In addition, the minimum bactericidal concentration (MBC) was measured by incubation of 20 µL of colorless content with Mueller--Hinton agar media, for 24 h at 37 °C. Gentamicin and vancomycin were applied as the positive control against Gram-positive and Gram-negative bacteria, respectively \[[@CR29]\].

To investigate the anti-fungal activity of DPKP-isolated allergens, different concentrations of DPKP-isolated allergens were prepared as previously mentioned in the antimicrobial assay. The volume was adjusted to 1 mL by SDB. Using twofold serial dilution technique, other concentrations of DPKP-isolated allergens were prepared. Then, 200 μL of cell suspension (10^6^ CFU/mL) was incubated for 48 h at 25 °C. Finally, the concentration with no visible microbial growth (i.e. MIC) and the concentration with no visible fungal growth \[i.e. minimum fungicidal concentration (MFC)\] were determined. In this experiment, the negative and positive controls were treated with SDB and nystatin, respectively \[[@CR22]\].

### Antiviral activity {#Sec16}

The *Coxsackie* viruses (*C*V) *B2*, *B3*, *B4* and *B5* were propagated in HEp-2 cells provided from National Cell Bank of Iran (Pasteur Institute, Tehran, Iran). Then, they were maintained in MEM supplemented with 10% heat-inactivated fetal calf serum (FCS), 1% (2 mM) [l]{.smallcaps}-Glutamine, 1% (50 μg/mL) streptomycin, 1% (50 IU/mL) penicillin, 1% non-essential amino acids and 1% (2.5 μg/mL) amphotericin B. The viruses titer was determined based on the 50% tissue culture infectious dose (TCID~50~) on HEp-2 cells and all viruses were stored at − 80 °C until use. The antiviral activity of DPKP-isolated allergens against *C*V *B2*, *B3*, *B4* and *B5* was studied with respect to their inhibitory activity on virus-induced cytopathogenicity and cell death in HEp-2 cells. HEp-2 cells were seeded into 96-well plates at 10^4^ cells/well at 37 °C with 5% CO~2~. After 24 h, the culture media was removed, and cells were washed two times with PBS before adding 100 μL of each DPKP-isolated allergen mixed with MEM 2% FCS (twofold dilutions, ranging from 3.9 to 1000 μg/mL). Cells were inoculated with 50 μL of 2% MEM containing 100 TCID~50~ of each *Coxsackie* virus (*B2-B5*). The MTT assay was performed for investigation of cell death due to virus infection. The virus inhibition percentages were measured using the following equation:
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Cytotoxicity assay {#Sec17}
------------------

### Cell culture {#Sec18}

Human ovarian carcinoma (A2780), human colon carcinoma (HTC), human glioblastoma (U-87-MG), human breast adenocarcinoma (MCF-7), and human prostate cell lines (PC3 and DU-145) were purchased from National Cell Bank of Iran (Pasteur Institute, Tehran, Iran). All cells were maintained at 37 °C in humidified (90%) atmosphere with 5% CO~2~ in RPMI 1640-supplemented with 10% (v/v) FBS, 100 IU/mL penicillin and 100 mg/mL streptomycin.

### Cell viability assay {#Sec19}

Cytotoxicity of DPKP-isolated allergens against human cancer cell lines was examined using MTT assay. Also, 3T3 was used as a normal cell line. Briefly, the cells (5 × 10^3^ per well) were seeded in a 96-well plate; after 24 h, for adhesion, different concentrations of each DPKP-isolated allergens were added to wells and all experiments were done in triplicate. After 48 h incubation, 10 µL of MTT (5 mg/mL stock solution) was added to each well and the plates were incubated at 37 °C for 4 h. The medium was removed and the formazan blue crystals were dissolved by 200 µL DMSO. The absorbance was measured at 570 nm by an ELISA microplate reader (Awareness Technology, Inc., Palm City, FL, USA). Cytotoxicity of each DPKP-isolated allergen was presented as its concentration inhibiting cell growth by 50% (IC~50~) and the percentage of viable cells was determined using the following equation (\[[@CR21]\]:
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Statistical analysis {#Sec20}
--------------------

Statistical analysis was performed as a completed randomized design (CRD) in triplicate and data are presented as mean ± SD. One way analysis of variance (ANOVA) and LSD test were performed to determine statistical differences among groups by JMP 8 (SAS Campus Drive, Cary, NC 27513) and Sigma Plot 12 software. The IC~50~ values were determined by GraphPad Prism 5.0 (GraphPad software, San Diego, CA, USA). Significant differences among mean values were determined by using LSD at the level of 0.05.

Results {#Sec21}
=======

Pistachio allergenic proteins purification {#Sec22}
------------------------------------------

### Method validation and protein content {#Sec23}

Protein content of each fraction was estimated using the Bradford assay. As shown in Table [1](#Tab1){ref-type="table"}, among three solvents used (i.e. 50 mM TRIS/HCl, pH 7.5; 0.01 M HCl pH 2.5 and 50 mM dibasic sodium phosphate, pH 8), the highest yields of protein extraction was recorded for TRIS/HCl; however, the difference between TRIS/HCl and dibasic sodium phosphate was not statistically significant (p ˂ 0.05). HCl could not completely extract the high molecular weight proteins. The Bradford assay indicated that protein contents of TRIS/HCl and dibasic sodium phosphate fractions were 77.4 and 70.2% with recovery of 90.2 and 89.3% of DPKP on a weight basis, respectively. Nevertheless, the HCl extract contained 33.5% total protein, and the percentage of its recovery represented 89.1% of DPKP on a weight basis.Table 1Total protein content and percentage of recovery in different fractionsFractionsProtein by weight on dry basis (%)Recovery (w/w%)TRIS/HCl77.4 ± 2.190.2 ± 1.5HCl33.5 ± 1.989.1 ± 1.5Dibasic sodium phosphate70.2 ± 2.189.3 ± 1.3

### Proteins purification and peptide markers {#Sec24}

The DPKP mass spectra taken at different retention time points showed numerous homogenous peaks with distinctive multiply charged ions that could easily determine the molecular weight.

Using our multiplexed LC--MS/MS analytical method, two marker peptides were detected based on retention times, accurate mass (in a 10 ppm window) and the product ions. The initial step in peptide selection included identification of the peptides. Among different detected proteins, two allergens are shown in Table [2](#Tab2){ref-type="table"} and Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}.Table 2Pistachio allergenic proteins profilesPeptide markerSequenceRT^a^ (min)Accurate mass (*m/z*)MS/MS sequenceMS/MS massProtein nameAllergen content (mg)Protein MW (KDa)pis2LQELYETASELPR25.5774.900519.41064.334Pis v 1 allergen 2 s albumin1.2 ± 0.0317.300Pis1TNGLSQTSQLAGR13.0666.848619.81307.123Pis v 2.0101 allergen 11 s globulin2.3 ± 0.0356.470^a^Retention timeFig. 1Mass spectrum of Pis v 2.0101 allergen 11 s globulinFig. 2Mass spectrum of Pis v 1 allergen 2 s albumin

Antimicrobial activity {#Sec25}
----------------------

### MIC and MBC values {#Sec26}

The antimicrobial activity of each DPKP-isolated allergen, namely Pis v 1 (allergen 2S albumin) and Pis v 2.0101 (allergen 11S globulin), was examined against eight bacteria and two fungi (Table [3](#Tab3){ref-type="table"}). According to the results, Pis v 1 and Pis v 2.0101 had similar MIC and MBC values of 16 and 12 µg/mL, respectively against *S. epidermis*. Also, it was observed that the most sensitive strain to these allergens was *S. epidermis*. Moreover, both allergens had similar MIC and MFC values of 12 and 10 µg/mL, respectively against *C. albicans*. In terms of antifungal activity, significant differences were observed between the allergens (Table [3](#Tab3){ref-type="table"}). Based on our results, MIC and MFC values against *C. albicans* and *A. niger* for Pis v 2.0101 were similarly 10 and 50 µg/mL, respectively (Table [3](#Tab3){ref-type="table"}).Table 3MICs and MBCs of Pis v 1 and Pis v 2.0101 against different bacterial and fungal strainsMicroorganismPis v 1Pis v 2.0101GentamicinVancomycinNystatinBacterial strainsMIC^a^MBC^b^MICMBCMICMBCMICMBCMICMBC* S. aureus* (PTCC 1431)501051225----432----* S. epidermis* (PTCC 1435)16161212----224----* B. cereus* (PTCC 1247)801406.2513.5----480----* M. luteus* (ATCC 9341)16161022----240----* E. coli* (ATCC 1533)90905011288--------* P. aeruginosa* (PTCC 1074)120250801451616--------* S. typhi* (PTCC 1609)*S. marcescens* (PTCC 1267)9212018012060609073.2168168--------Fungal strainsMICMFC^c^MICMFCMICMFCMICMFCMICMFC* C. albican*s (ATCC 10231)12121010--------44* A. niger* (ATCC 16404)20305050--------88^a^Minimum inhibitory concentration (µg/mL)^b^Minimum bactericidal concentration (µg/mL)^c^Minimum fungicidal concentration (µg/mL)

Antiviral activity {#Sec27}
------------------

### Inhibition of *Coxsackie* viruses (*C*V-*B2-5*) infectivity by DPKP-isolated allergens {#Sec28}

The antiviral activity of different concentrations of the two allergens was evaluated against *Coxsackie* viruses (*B2-B5*) at 37 °C (Fig. [3](#Fig3){ref-type="fig"}). The virus assay examined the inhibitory effects of the compounds on virus- induced pathogenicity in HEp-2 cells. Our results proved that both of these allergens are active against *Coxsackie* viruses (*B2-B5*) and the lowest IC~50~ values for both allergens were observed for *C*V*-B4*. IC~50~ values calculated for Pis v 2.0101 were significantly lower than those of Pis v 1 against all cell lines (Table [4](#Tab4){ref-type="table"}). The selectivity indexes (SI) (CC~50~/IC~50~) of both allergens for all CVs were \> 3. Generally, 50% cytotoxic concentration (CC~50~) is considered a useful marker in cytotoxicity. Based on our results, the CC~50~ of Pis v 2.0101 against all cell lines was 710.30 ± 1.03 (Table [4](#Tab4){ref-type="table"}). A CC~50~ of 100--1000 µg/mL shows moderate cytotoxicity. It seems that the antiviral activity is appropriate when the samples tested have an IC~50~ values below 100 µg/mL \[[@CR4]\].Fig. 3Antiviral activity of Pis v 1 allergen 2S albumin and Pis v 2.0101 allergen 11S globulin against **a***Coxsackie* virus *B2*; **b***Coxsackie* virus *B3*; **c***Coxsackie* virus *B4* and **d***Coxsackie* virus *B5*Table 4Virucidal activity of Pis v 1 and Pis v 2.0101*Coxsackie* virusPis v 1Pis v 2.0101CC~50~^a^IC~50~^b^SI^c^CC~50~IC~50~SI*C*V*-B2*352.20 ± 1.0348.05 ± 0.907.33648.75 ± 1.0237.50 ± 1.0117.30*C*V*-B3*516.25 ± 1.0543.75 ± 1.0111.80649.88 ± 1.0135.61 ± 1.0318.25*C*V*-B4*633.88 ± 1.0138.77 ± 1.0216.35710.30 ± 1.0330.20 ± 1.0123.52*C*V*-B5*586.73 ± 1.0241.29 ± 1.0314.21648.42 ± 1.0331.77 ± 1.0220.41^a^The 50% cytotoxic concentration for target cells (µg/mL)^b^The concentration of the sample required for 50% inhibition (µg/mL)^c^Selectivity index

Cytotoxicity {#Sec29}
------------

Cytotoxicity of the two isolated allergens was investigated using MTT method against six human cancer cell lines (Table [5](#Tab5){ref-type="table"}). Doxorubicin was used as the positive control. The results are summarized in Table [5](#Tab5){ref-type="table"}. Both allergens had potent cytotoxic effects toward all cancer cell lines at all tested concentrations (IC~50~ values \< 100 µg/mL). Comparison made between the two allergens showed that IC~50~ values of Pis v 2.0101 were significantly lower than those of Pis v 1 against all cell lines (Table [5](#Tab5){ref-type="table"}).Table 5Cytotoxic activity (IC~50~) of Pis v 1 and Pis v 2.0101Cell linePis v 1Pis v 2.0101DoxorubicinMCF-725.71 ± 0.9428.11 ± 0.880.78 ± 0.05A278030.06 ± 0.7133.95 ± 0.420.61 ± 0.02PC331.74 ± 0.6334.05 ± 0.420.44 ± 0.05DU-14534.52 ± 0.9038.63 ± 0.800.98 ± 0.05U-87-MG21.09 ± 0.5526.34 ± 0.880.39 ± 0.05HTC25.71 ± 0.9428.11 ± 0.880.78 ± 0.05Data are shown as mean (± SD)IC~50~: the concentration required for 50% inhibition (µg/mL)

Discussion {#Sec30}
==========

Since synthetic antibiotics have become less effective or even ineffective, peptides have been considered for development of new antibiotics. Many peptides are known to play important roles in immunomodulation, promotion of wound healing during the clearance of infection, and antiviral activity against HIV-1. They can incorporate into the eukaryotic cells and interact with the members of mitochondria inducing membrane depolarization and tumor cell death via activation of mitochondrial apoptotic pathways \[[@CR20]\]. In the present work, we found that these allergens have considerable antimicrobial effects against Gram-positive, Gram-negative and fungal as well as *Coxsackie* viruses and possess A2780, HTC, U-87-MG, MCF-7, PC3, DU-145 cytotoxic properties. It was previously shown that melittin isolated from the venom of Iranian honey bee, possesses broad antimicrobial spectra as well as anticancer properties \[[@CR20]\]. By the advent of molecular biology techniques, many studies examined antibacterial, antifungal, antiviral, and anticancer activities of proteins isolated from different sources such as plants, mammals, marine invertebrates, and insects. For example, the peptide obtained from the wheat endosperm, purothionin, showed antibiotic activities \[[@CR15]\]. The cytoplasmic membranes of microbes are lipid-rich and the antimicrobial proteins can easily interact with the cytoplasmic membrane of pathogens using their charged- hydrophobic structure \[[@CR17]\]. Based on our antimicrobial assessments, the most susceptible strains were Gram-positive bacteria. Biological evaluations revealed that it is easier for antimicrobial proteins to enter Gram-positive peptidoglycan layer compared to Gram-negative hydrophilic lipopolysaccharides (LPS) which show higher degree of resistance towards hydrophobic antimicrobial compounds \[[@CR23]\].

Recently, many viral diseases were treated with a combination of synthetic drugs which improve sustained virological response, but also produce adverse side effects including anemia and gastrointestinal symptoms \[[@CR14]\]. In addition, antimicrobial proteins can exhibit antitumor and antiviral effects \[[@CR27]\]. It has been reported that two allergens of pistachio inhibited several group B *Coxsackie* viruses*.* Pharmacological activities of pistachio allergens were attributed to their antiviral potential. Our data showed that both allergens, markedly affected *C*V*-B2-5* viability. Viral membrane fusion inhibitory activity of these proteins may be related to their lipopeptide- based structure \[[@CR37]\]. It was indicated that tryptophan- rich, C8 (Ac-Trp-Glu-Asp-Trp-Val-Gly-Trp-Ile-NH2) plays a major role against the membrane- proximal external region of the feline immune deficiency virus (FIV) \[[@CR8]\]. It seems that the inhibitory action is related to adsorption of the peptide on the plasma membrane of the target cell, where it can inhibit interactions between virus fusion glycoprotein \[[@CR7]\]. Adsorbed peptide supports the cell from the fusion glycoprotein of the virus and it is directly due to the fundamental peptide; however, small peptides may exhibit no antiviral activity because of their conformational instability \[[@CR8]\]. In another study using FTIR spectroscopy, a secondary structure consisting of an N-terminal beta-sheet along with a turn and C-terminal beta-sheet was introduced as a new class of anti-HCV compounds \[[@CR14]\].

Proteins have been regarded as candidates for treatment of cancer or inflammatory diseases and were shown to trigger apoptosis and prevent angiogenesis. Anticancer proteins are able to stimulate host defense system cells and tissues via direct and indirect interaction with host's genes and proteins \[[@CR27]\].

In our study, pistachio allergens produced potent cytotoxicity in a concentration- dependent manner against all six cell lines. Interestingly, HTC cells were found to be more sensitive to the cytotoxic effects of both allergens compared to the other cell lines. In a previous study, R-lycosin-I modified by amino acid substitution from lycosin-I, showed anticancer activity and inhibited cell proliferation \[[@CR12]\]. In another research, fatty acids with different chain lengths were introduced to the N-terminal of R-lycosin-I; this modification increased cytotoxic activity of these lipopeptides against A549 cells \[[@CR12]\]. Also, Tag7 was reported to be an innate immune protein that is involved in the antibacterial and antitumor effects \[[@CR24]\]. Moreover, Tag7 complex with Hsp70 showed cytotoxic effects in many tumor cell lines. It seems that Tag7 can activate cytotoxic lymphocyte subpopulations \[[@CR25]\]. Cytotoxicity of proteins may be exerted through different mechanisms including disruption of cell membrane integrity via depolarization, reducing the activity of membrane- bound enzymes, modification of the mevalonate pathway of metabolism and/or induction of apoptosis \[[@CR35]\].

Conclusion {#Sec31}
==========

The two allergens isolated from pistachio in this study, presented considerable effects against biofilm-related infections, *C*V*-B2-5*, and several cell lines. These observations could be used as a basis for future experiments to further evaluate potential therapeutic applications of these proteins.
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